Lung (Neoplasm) Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2009	Tools used in the diagnosis and staging of lung cancer: what's old and what's new?	+	-	nl	QJM 102(7):443-8 (2009)
2	2009	Lung cancer: current diagnosis and treatment.	+	-	nl	Dtsch Arztebl Int 106(49):809-18; quiz 819-20 (2009)
3	2008	Adjuvant chemotherapy after complete resection of non-small cell lung cancer.	+	-	nl	Dtsch Arztebl Int 105(14):249-54 (2008) Laack E
4	2008	Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.	+	-	nl	Eur J Cardiothorac Surg 34(1):187-95 (2008)
5	2004	Surgical treatment of Pancoast tumours.	+	-	nl	Eur J Cardiothorac Surg 26(1):202-8 (2004)
6	2003	Pulmonary large-cell neuroendocrine carcinoma (LCNEC).	+	-	nl	Eur J Cardiothorac Surg 23(4):457-60 (2003)
7	2000	Long-term outcome after resection for bronchial carcinoid tumors.	+	-	nl	Eur J Cardiothorac Surg 18(2):156-61 (2000)
8	2000	Mucoepidermoid bronchial tumors: a review of 34 operated cases.	+	-	nl	Eur J Cardiothorac Surg 17(5):566-9 (2000)
9	1998	Localized fibrous tumours of the pleura: 15 new cases and review of the literature.	+	-	nl	Eur J Cardiothorac Surg 14(5):453-9 (1998)
10	1993	Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients.	+	-	nl	Eur J Cardiothorac Surg 7(1):8-11 (1993)
11	1993	Bronchial carcinoids.	+	-	nl	Eur J Cardiothorac Surg 7(7):347-50 (1993)
12	1990	Pulmonary hamartoma. A clinical study of 77 cases in a 21-year period and review of literature.	+	-	nl	Eur J Cardiothorac Surg 4(1):15-8 (1990)
13	2009	EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab.	+	-	nl	Biologics 3(-):215-24 (2009)
14	2007	Review of erlotinib in the treatment of advanced non-small cell lung cancer.	+	-	nl	Biologics 1(4):335-46 (2007)
15	2010	The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.	+	-	nl	Health Technol Assess 14(19):1-204 (2010)
16	2009	Erlotinib for the treatment of relapsed non-small cell lung cancer.	+	-	nl	Health Technol Assess 13 Suppl 1(-):41-7 (2009)
17	2006	The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.	+	-	nl	Health Technol Assess 10(3):iii-iv, ix-x, 1-90 (2006)
18	1958	The solitary pulmonary nodule; a review of 236 consecutive cases, 1944 to 1956.	+	-	nl	Ann Surg 147(2):197-202 (1958)
19	2008	First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view.	+	-	nl	BMC Proc 2 Suppl 2(-):S3 (2008)
20	2001	Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.	+	-	nl	BMC Cancer 1(-):5 (2001)
21	2010	Systemic therapies in metastatic non-small-cell lung cancer with emphasis on targeted therapies: the rational approach.	+	-	nl	Curr Oncol 17(2):13-23 (2010)
22	2010	Impact of biomarkers on non-small cell lung cancer treatment.	+	-	nl	Target Oncol 5(1):5-17 (2010)
23	2009	Anatomy, biology and concepts, pertaining to lung cancer stage classification.	+	-	nl	J Thorac Oncol 4(4):437-43 (2009)
24	2009	Preinvasive lesions of the bronchus.	+	-	nl	J Thorac Oncol 4(4):545-51 (2009)
25	2008	Turning gray: the natural history of lung cancer over time.	+	-	nl	J Thorac Oncol 3(7):781-92 (2008)
26	2008	EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer.	+	-	nl	J Thorac Oncol 3(3):303-10 (2008)
27	2007	Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.	+	-	nl	J Thorac Oncol 2(4):348-54 (2007)
28	2007	A translational view of the molecular pathogenesis of lung cancer.	+	-	nl	J Thorac Oncol 2(4):327-43 (2007)
29	2006	A review of first-line treatment for small-cell lung cancer.	+	-	nl	J Thorac Oncol 1(3):270-8 (2006)
30	2008	Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.	+	-	nl	Ann Oncol 19 Suppl 2(-):ii41-2 (2008)
31	2008	Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.	+	-	nl	Ann Oncol 19 Suppl 2(-):ii39-40 (2008)
32	2006	The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy.	+	-	nl	Ann Oncol 17 Suppl 10(-):x108-12 (2006)
33	2006	Expanding role of chemotherapy in lung cancer.	+	-	nl	Ann Oncol 17 Suppl 10(-):x101-7 (2006)
34	2006	Second-line chemotherapy for non-small cell lung cancer.	+	-	nl	Ann Oncol 17 Suppl 5(-):v68-71 (2006)
35	2006	First line chemotherapy in advanced or metastatic NSCLC.	+	-	nl	Ann Oncol 17 Suppl 5(-):v64-7 (2006)
36	2006	Current status of adjuvant chemotherapy in NSCLC.	+	-	nl	Ann Oncol 17 Suppl 5(-):v62-3 (2006)
37	2006	Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC).	+	-	nl	Ann Oncol 17 Suppl 5(-):v55-61 (2006)
38	2006	Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.	+	-	nl	Ann Oncol 17 Suppl 5(-):v52-4 (2006)
39	2006	Development of gemcitabine in non-small cell lung cancer: the Italian contribution.	+	-	nl	Ann Oncol 17 Suppl 5(-):v37-46 (2006)
40	2006	10-year update on chemotherapy for non-small cell lung cancer.	+	-	nl	Ann Oncol 17 Suppl 5(-):v33-36 (2006)
41	2006	Clinical studies of pemetrexed and gemcitabine combinations.	+	-	nl	Ann Oncol 17 Suppl 5(-):v29-32 (2006)
42	2006	Prophylactic cranial irradiation in non-small cell lung cancer.	+	-	nl	Ann Oncol 17 Suppl 2(-):ii76-78 (2006)
43	2006	Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy.	+	-	nl	Ann Oncol 17 Suppl 2(-):ii73-75 (2006)
44	2006	Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery.	+	-	nl	Ann Oncol 17 Suppl 2(-):ii71-72 (2006)
45	2006	Maintenance chemotherapy in non-small cell lung cancer.	+	-	nl	Ann Oncol 17 Suppl 2(-):ii67-70 (2006)
46	2006	Small cell lung cancer.	+	-	nl	Ann Oncol 17 Suppl 2(-):ii5-10 (2006)
47	2006	Treatment of advanced non-small cell lung cancer.	+	-	nl	Ann Oncol 17 Suppl 2(-):ii36-41 (2006)
48	2006	New radiation techniques for treatment of locally advanced non-small cell lung cancer (NSCLC).	+	-	nl	Ann Oncol 17 Suppl 2(-):ii34-35 (2006)
49	2002	Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients.	+	-	nl	Ann Oncol 13(5):748-54 (2002)
50	2008	Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.	+	-	nl	Cancer 112(5):1106-13 (2008)
51	2007	Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors.	+	-	nl	Cancer 110(10):2253-9 (2007)
52	2007	Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.	+	-	nl	Cancer 109(5):939-48 (2007)
53	2006	Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors.	+	-	nl	Cancer 107(12):2873-80 (2006)
54	2000	Multiple chondromatous hamartomas of the lung: a case report and review of the literature with special reference to Carney syndrome.	+	-	nl	Cancer 88(4):964-5 (2000)
55	2007	Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer.	+	-	nl	Cancer Control 14(1):57-62 (2007)
56	2006	Large-cell neuroendocrine carcinoma of the lung.	+	-	nl	Cancer Control 13(4):270-5 (2006)
57	2006	Solitary fibrous tumor of the pleura.	+	-	nl	Cancer Control 13(4):264-9 (2006)
58	2006	Understanding the uncommon thoracic tumors.	+	-	nl	Cancer Control 13(4):252-3 (2006)
59	2001	NCCN: Small cell lung cancer.	+	-	nl	Cancer Control 8(6 Suppl 2):32-43 (2001)
60	2001	NCCN: Non-small cell lung cancer.	+	-	nl	Cancer Control 8(6 Suppl 2):22-31 (2001)
61	2001	Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.	+	-	nl	Cancer Control 8(4):326-36 (2001)
62	2001	Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.	+	-	nl	Clin Cancer Res 7(1):5-22 (2001)
63	1998	New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.	+	-	nl	Clin Cancer Res 4(5):1087-100 (1998)
64	1997	Combined modality therapy of lung cancer.	+	-	nl	Clin Cancer Res 3(12 Pt 2):2638-47 (1997)
65	2007	18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.	+	-	nl	J Natl Cancer Inst 99(23):1753-67 (2007) Ung YC
66	2007	Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.	+	-	nl	J Natl Cancer Inst 99(11):847-57 (2007) Ardizzoni A
67	2007	Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.	+	-	nl	J Natl Cancer Inst 99(11):828-9 (2007)
68	2009	The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.	+	-	nl	Oncologist 14(4):412-24 (2009)
69	2009	The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.	+	-	nl	Oncologist 14(3):253-63 (2009)
70	2008	Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.	+	-	nl	Oncologist 13(9):945-53 (2008)
71	2008	Critical review of nonsurgical treatment options for stage I non-small cell lung cancer.	+	-	nl	Oncologist 13(3):309-19 (2008)
72	2008	Considerations for second-line therapy of non-small cell lung cancer.	+	-	nl	Oncologist 13 Suppl 1(-):28-36 (2008)
73	2008	Local control of regional and metastatic lesions and indication for systemic chemotherapy in patients with non-small cell lung cancer.	+	-	nl	Oncologist 13 Suppl 1(-):21-7 (2008)
74	2008	Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer.	+	-	nl	Oncologist 13 Suppl 1(-):14-20 (2008)
75	2008	Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.	+	-	nl	Oncologist 13 Suppl 1(-):5-13 (2008)
76	2008	CT screening for lung cancer: update 2007.	+	-	nl	Oncologist 13(1):65-78 (2008)
77	2007	Recent advances with topotecan in the treatment of lung cancer.	+	-	nl	Oncologist 12(10):1194-204 (2007)
78	2007	The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments.	+	-	nl	Oncologist 12(10):1183-93 (2007)
79	2007	Erlotinib in non-small cell lung cancer treatment: current status and future development.	+	-	nl	Oncologist 12(7):840-9 (2007)
80	2007	Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.	+	-	nl	Oncologist 12(4):451-64 (2007)
81	2006	Combined modality therapy for stage III non-small cell lung cancer.	+	-	nl	Oncologist 11(7):809-23 (2006)
82	2006	Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selection.	+	-	nl	Oncologist 11(6):655-65 (2006)
83	2005	Treatment of small cell lung cancer in the elderly.	+	-	nl	Oncologist 10(6):399-411 (2005)
84	2001	Lung cancer.	+	-	nl	Oncologist 6(5):407-14 (2001)
85	2000	Prophylactic cranial irradiation in small-cell lung cancer.	+	-	nl	Oncologist 5(4):293-8 (2000)
86	2008	Second-line and third-line chemotherapy for lung cancer: use and cost.	+	-	nl	Am J Manag Care 14(5):297-306 (2008)
87	2004	Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.	+	-	nl	Ann Intern Med 140(9):740-53 (2004)
88	2004	Lung cancer screening: recommendation statement.	+	-	nl	Ann Intern Med 140(9):738-9 (2004)
89	2009	A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.	+	-	nl	Ann Thorac Cardiovasc Surg 15(4):213-20 (2009)
90	2008	Staging of lung cancer.	+	-	nl	Chest 133(3):593-5 (2008) Milroy R
91	2007	Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):324S-339S (2007)
92	2007	Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):314S-323S (2007)
93	2007	Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):306S-13S (2007)
94	2007	Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):290S-305S (2007)
95	2007	Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):277S-289S (2007)
96	2007	Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):266S-276S (2007)
97	2007	Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):243S-265S (2007)
98	2007	Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):234S-242S (2007)
99	2007	Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):221S-233S (2007)
100	2007	Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):202S-220S (2007)
101	2007	Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):178S-201S (2007)
102	2007	Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):161S-77S (2007)
103	2007	Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):149S-160S (2007)
104	2007	Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):131S-148S (2007)
105	2007	Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):108S-130S (2007)
106	2007	Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):94S-107S (2007)
107	2007	Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):78S-93S (2007)
108	2007	Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):69S-77S (2007)
109	2006	Long-term survivorship in lung cancer: a review.	+	-	nl	Chest 129(4):1088-97 (2006)
110	2004	Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies.	+	-	nl	Chest 126(4):1318-29 (2004)
111	2003	Surgical treatment of malignant pleural mesothelioma: a review.	+	-	nl	Chest 123(2):551-61 (2003)
112	2003	Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes.	+	-	nl	Chest 123(1 Suppl):97S-104S (2003)
113	2000	Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia.	+	-	nl	Chest 117(4 Suppl 1):80S-89S (2000)
114	1999	Advances in the treatment of malignant pleural mesothelioma.	+	-	nl	Chest 116(2):504-20 (1999)
115	1998	Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients.	+	-	nl	Chest 113(2):391-5 (1998)
116	1993	Natural history and epidemiology of malignant mesothelioma.	+	-	nl	Chest 103(4 Suppl):373S-376S (1993)
117	2002	Diagnostic imaging of lung cancer.	+	-	nl	Eur Respir J 19(4):722-42 (2002)
118	2001	The new World Health Organization classification of lung tumours.	+	-	nl	Eur Respir J 18(6):1059-68 (2001)
119	1998	Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression.	+	-	nl	Eur Respir J 12(1):89-96 (1998)
120	1995	Biological and immunological aspects of malignant mesothelioma.	+	-	nl	Eur Respir J 8(4):643-50 (1995)
121	1994	Serum tumour markers in lung cancer: history, biology and clinical applications.	+	-	nl	Eur Respir J 7(1):186-97 (1994)
122	2007	New molecularly targeted therapies for lung cancer.	+	-	nl	J Clin Invest 117(10):2740-50 (2007)
123	2006	Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.	+	-	nl	J Clin Pathol 59(8):790-800 (2006)
124	1987	Pulmonary adenocarcinoma: review of 106 cases and proposed new classification.	+	-	nl	J Clin Pathol 40(2):125-35 (1987)
125	2008	Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.	+	-	nl	Mayo Clin Proc 83(5):584-94 (2008)
126	2008	Small cell lung cancer.	+	-	nl	Mayo Clin Proc 83(3):355-67 (2008)
127	2009	Current treatments for advanced stage non-small cell lung cancer.	+	-	nl	Proc Am Thorac Soc 6(2):233-41 (2009)
128	2009	Adjuvant treatment of resected lung cancer.	+	-	nl	Proc Am Thorac Soc 6(2):194-200 (2009)
129	2002	Preneoplastic lesions of the lung.	+	-	nl	Respir Res 3(-):20 (2002)
130	1987	Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases.	+	-	nl	Thorax 42(10):790-3 (1987)
131	1984	Alveolar carcinoma: a review.	+	-	nl	Thorax 39(3):166-74 (1984)
132	1984	Histological classification of lung cancer.	+	-	nl	Thorax 39(3):161-5 (1984)
133	1982	Diffuse malignant mesothelioma: a review.	+	-	nl	West J Med 137(6):548-54 (1982)
134	2007	Pictorial review of the many faces of bronchioloalveolar cell carcinoma.	+	-	nl	Br J Radiol 80(960):1015-23 (2007)
135	2001	Lung cancer screening.	+	-	nl	Br J Radiol 74(882):478-85 (2001)
136	2008	Pulmonary nodules: detection, assessment, and CAD.	+	-	nl	AJR Am J Roentgenol 191(4):1057-69 (2008)
137	2008	Screening for lung cancer.	+	-	nl	AJR Am J Roentgenol 190(3):755-61 (2008)
138	2007	Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment.	+	-	nl	AJR Am J Roentgenol 188(1):57-68 (2007)
139	2005	Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT.	+	-	nl	AJR Am J Roentgenol 185(4):979-84 (2005)
140	1994	Lymphoproliferative disorders of the lung: histopathology, clinical manifestations, and imaging features.	+	-	nl	AJR Am J Roentgenol 163(2):273-81 (1994)
141	1992	Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.	+	-	nl	AJR Am J Roentgenol 159(5):961-6 (1992)
142	1990	Pitfalls in the radiologic diagnosis of lung cancer.	+	-	nl	AJR Am J Roentgenol 154(6):1165-75 (1990)
143	1990	Radiologic evaluation of the solitary pulmonary nodule.	+	-	nl	AJR Am J Roentgenol 154(4):701-8 (1990)
144	1983	Leiomyomatous lung lesions: a proposed classification.	+	-	nl	AJR Am J Roentgenol 141(2):269-72 (1983)
145	1977	1976 Caldwell Lecture: varying manifestation of peripheral pulmonary neoplasms: a radiologic-pathologic correlative study.	+	-	nl	AJR Am J Roentgenol 128(6):893-914 (1977)
146	1976	Pulmonary blastoma: case report and literature review.	+	-	nl	AJR Am J Roentgenol 127(6):1048-9 (1976)
147	2005	Utility of 18F-FDG PET in evaluating cancers of lung.	+	-	nl	J Nucl Med Technol 33(2):69-74; quiz 75-7 (2005)
148	2009	Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis.	+	-	nl	J Nucl Med 50(3):376-81 (2009)
149	1999	PET in lung cancer.	+	-	nl	J Nucl Med 40(5):814-20 (1999)
150	2006	From the archives of the AFIP: Pleuropulmonary synovial sarcoma.	+	-	nl	Radiographics 26(3):923-40 (2006)
151	2002	Unusual primary lung tumors: a radiologic-pathologic overview.	+	-	nl	Radiographics 22(3):601-19 (2002)
152	2001	Oncodiagnosis panel: 1999. Cancer of the lung: oncodiagnosis.	+	-	nl	Radiographics 21(6):1573-96 (2001)
153	1997	Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings.	+	-	nl	Radiographics 17(6):1345-57 (1997)
154	1994	Bronchogenic carcinoma: radiologic-pathologic correlation.	+	-	nl	Radiographics 14(2):429-46; quiz 447-8 (1994)
155	1992	CT of focal pulmonary masses in childhood.	+	-	nl	Radiographics 12(3):505-14 (1992)
156	2005	Case report: pulmonary blastoma: presentation of two atypical cases and review of the literature.	+	-	nl	Br J Radiol 78(929):437-40 (2005)
157	2005	Imaging of the patient with non-small cell lung cancer.	+	-	nl	Radiology 237(3):803-18 (2005)
158	2005	Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.	+	-	nl	Radiology 237(2):395-400 (2005)
159	2005	Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema.	+	-	nl	Radiology 235(1):266-73 (2005)
160	2008	Molecular diagnosis of lung cancer: an overview of recent developments.	+	-	nl	Acta Biomed 79 Suppl 1(-):11-23 (2008)
161	2002	Interventional palliative treatment options for lung cancer.	+	-	nl	Ann Oncol 13 Suppl 4(-):247-50 (2002)
162	2010	Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.	+	-	nl	Ann Oncol 21 Suppl 5(-):v103-15 (2010)
163	2010	Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.	+	-	nl	Ann Oncol 21 Suppl 5(-):v116-9 (2010)
164	2010	Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.	+	-	nl	Ann Oncol 21 Suppl 5(-):v120-5 (2010)
165	2010	Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?	+	-	nl	Ann Oncol 21 Suppl 7(-):vii196-8 (2010)
166	2010	Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?	+	-	nl	Ann Oncol 21 Suppl 7(-):vii199-202 (2010)
167	2010	Should we continue to use the term non-small-cell lung cancer?	+	-	nl	Ann Oncol 21 Suppl 7(-):vii225-9 (2010)
168	2010	How to integrate current knowledge in selecting patients for first line in NSCLC?	+	-	nl	Ann Oncol 21 Suppl 7(-):vii230-3 (2010)
169	2010	Consequences of targeted treatments for second-line therapy.	+	-	nl	Ann Oncol 21 Suppl 7(-):vii234-40 (2010)
170	2010	Early stage non-small-cell lung cancer: challenges in staging and adjuvant treatment: evidence-based staging.	+	-	nl	Ann Oncol 21 Suppl 7(-):vii189-95 (2010)
171	2009	Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.	+	-	nl	Ann Oncol 20 Suppl 4(-):68-70 (2009)
172	2009	Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.	+	-	nl	Ann Oncol 20 Suppl 4(-):71-2 (2009)
173	2010	Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice.	+	-	nl	Ann Oncol 21(2):428-9 (2010)
174	2010	New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.	+	-	nl	AJR Am J Roentgenol 195(3):W221-8 (2010)
175	2010	A radiologic review of the new TNM classification for lung cancer.	+	-	nl	AJR Am J Roentgenol 194(3):562-73 (2010)
176	2010	Multiple cystlike lung lesions in the adult.	+	-	nl	AJR Am J Roentgenol 194(1):W1-W11 (2010)
177	2009	Staging of non-small cell lung cancer using integrated PET/CT.	+	-	nl	AJR Am J Roentgenol 193(5):1203-11 (2009)
178	2008	Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management.	+	-	nl	Radiographics 28(2):551-60; quiz 620 (2008)
179	2008	Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response.	+	-	nl	Radiographics 28(2):561-72 (2008)
180	2011	SEPAR guidelines for lung cancer staging.	+	-	nl	Arch Bronconeumol 47(9):454-65 (2011)
181	2011	Primary pulmonary mucinous cystadenocarcinoma: presentation of a case and a review of the literature.	+	-	nl	Arch Bronconeumol 47(4):216-7 (2011)
182	2004	The diagnosis of bronchioloalveolar carcinoma by cytologic means.	+	-	nl	Am J Clin Pathol 122(1):14-6 (2004)
183	2009	Micropapillary histology: a frequent morphology of mutation-associated lung adenocarcinoma?	+	-	nl	Am J Clin Pathol 131(5):615-7 (2009)
184	2005	The spectrum of pulmonary mucinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of literature.	+	-	nl	Am J Clin Pathol 124(1):62-70 (2005)
185	2011	A systemic review of PET and biology in lung cancer.	+	-	nl	Am J Transl Res 3(4):383-91 (2011)
186	2007	Computed tomography screening for lung cancer.	+	-	nl	BMJ 334(7588):271 (2007)
187	2010	Novel insights into the molecular origins and treatment of lung cancer.	+	-	nl	Cell Cycle 9(20):4098-105 (2010)
188	2004	Pulmonary epithelioid hemangioendothelioma: an unusual case and a review of the literature.	+	-	nl	Chest 125(2):789-93 (2004)
189	2003	Lung cancer. Special treatment issues.	+	-	nl	Chest 123(1 Suppl):244S-258S (2003)
190	2003	Small cell lung cancer.	+	-	nl	Chest 123(1 Suppl):259S-271S (2003)
191	2010	PET scans for lung nodules: costs and cost-effectiveness.	+	-	nl	Chest 137(1):4-6 (2010) Arenberg D
192	2007	Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).	+	-	nl	Chest 132(3 Suppl):340S-354S (2007)
193	2007	Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition).	+	-	nl	Chest 132(3 Suppl):355S-367S (2007)
194	2009	The new lung cancer staging system.	+	-	nl	Chest 136(1):260-71 (2009) Detterbeck FC
195	2004	Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.	+	-	nl	Radiology 233(3):793-8 (2004)
196	2009	Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management.	+	-	nl	Radiology 253(3):606-22 (2009)
197	2007	Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.	+	-	nl	Radiology 242(3):882-8 (2007)
198	2009	Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening.	+	-	nl	Radiology 251(3):919-25 (2009)
199	2009	Noncalcified lung nodules: volumetric assessment with thoracic CT.	+	-	nl	Radiology 251(1):26-37 (2009)
200	2008	Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients.	+	-	nl	Radiology 247(3):871-9 (2008)
201	2008	Comparison of chest tomosynthesis and chest radiography for detection of pulmonary nodules: human observer study of clinical cases.	+	-	nl	Radiology 249(3):1034-41 (2008)
202	2008	Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.	+	-	nl	Radiology 248(1):278-87 (2008)
203	2011	The role of proteasome inhibition in nonsmall cell lung cancer.	+	-	nl	J Biomed Biotechnol 2011(-):806506 (2011)
204	2011	Target therapies in lung cancer.	+	-	nl	J Biomed Biotechnol 2011(-):921231 (2011)
205	2009	Chemoprevention of lung cancer.	+	-	nl	Proc Am Thorac Soc 6(2):187-93 (2009)
206	2005	What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.	+	-	nl	Thorax 60(12):1059-65 (2005)
207	2003	Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.	+	-	nl	Thorax 58(3):266-71 (2003)
208	2007	Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection.	+	-	nl	Thorax 62(5):391-5 (2007)
209	2007	Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.	+	-	nl	Thorax 62(3):248-52 (2007)
210	2011	Approach to multiple pulmonary nodules: a case report and review of literature.	+	-	nl	ScientificWorldJournal 11(-):760-5 (2011)
211	2010	Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.	+	-	nl	J Clin Endocrinol Metab 95(7):3111-7 (2010)
212	2010	Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.	+	-	nl	Discov Med 9(49):538-45 (2010)
213	2011	Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review.	+	-	nl	PLoS One 6(11):e26646 (2011)
214	2011	Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis.	+	-	nl	PLoS One 6(8):e22681 (2011)
215	2007	The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer.	+	-	nl	Clin Cancer Res 13(15 Pt 2):s4637-40 (2007)
216	2007	HKI-272 in non small cell lung cancer.	+	-	nl	Clin Cancer Res 13(15 Pt 2):s4593-6 (2007)
217	2007	Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumab.	+	-	nl	Clin Cancer Res 13(15 Pt 2):s4597-601 (2007)
218	2009	Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.	+	-	nl	Clin Cancer Res 15(10):3600-9 (2009)
219	2009	Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.	+	-	nl	Clin Cancer Res 15(13):4493-8 (2009)
220	2009	Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.	+	-	nl	Clin Cancer Res 15(16):5040-8 (2009)
221	2009	Lung cancer in never smokers: molecular profiles and therapeutic implications.	+	-	nl	Clin Cancer Res 15(18):5646-61 (2009)
222	2009	Lung cancer in never smokers: clinical epidemiology and environmental risk factors.	+	-	nl	Clin Cancer Res 15(18):5626-45 (2009)
223	2006	Mouse models of lung cancer.	+	-	nl	Clin Cancer Res 12(14 Pt 2):4396s-4402s (2006)
224	2010	Adjuvant therapy in non-small cell lung cancer: current and future directions.	+	-	nl	Oncologist 15(8):862-72 (2010)
225	2010	Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.	+	-	nl	Oncologist 15(10):1034-42 (2010)
226	2010	Histology matters: individualizing treatment in non-small cell lung cancer.	+	-	nl	Oncologist 15(1):3-5 (2010)
227	2010	Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.	+	-	nl	Oncologist 15(2):187-95 (2010)
228	2010	Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review.	+	-	nl	Oncologist 15(1):93-103 (2010)
229	2007	Indications and developments of video-assisted thoracic surgery in the treatment of lung cancer.	+	-	nl	Oncologist 12(10):1205-14 (2007)
230	2007	Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.	+	-	nl	Oncologist 12(3):325-30 (2007)
231	2007	Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses.	+	-	nl	Oncologist 12(1):79-89 (2007)
232	2005	Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab.	+	-	nl	Oncologist 10(4):282-91 (2005)
233	2009	Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC.	+	-	nl	Oncologist 14(4):399-411 (2009)
234	2009	Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer.	+	-	nl	Oncologist 14(6):612-20 (2009)
235	2009	Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancer.	+	-	nl	Oncologist 14(6):601-11 (2009)
236	2009	The role of EGFR inhibition in the treatment of non-small cell lung cancer.	+	-	nl	Oncologist 14(11):1116-30 (2009)
237	2009	Pulmonary neuroendocrine/carcinoid tumors: a review article.	+	-	nl	Cancer 115(19):4434-41 (2009)
238	2008	LKB1 and lung cancer: more than the usual suspects.	+	-	nl	Cancer Res 68(10):3562-5 (2008)
239	2006	Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.	+	-	nl	Br J Cancer 94(10):1383-8 (2006)
240	2010	Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer.	+	-	nl	Br J Cancer 103(9):1325-30 (2010)
241	2004	The epidemiology of interstitial lung disease and its association with lung cancer.	+	-	nl	Br J Cancer 91 Suppl 2(-):S3-10 (2004)
242	2007	How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.	+	-	nl	Br J Cancer 96(10):1498-503 (2007)
243	2010	Update in lung cancer and mesothelioma 2009.	+	-	nl	Am J Respir Crit Care Med 181(8):773-81 (2010)
244	2011	The morphological and molecular diagnosis of lung cancer.	+	-	nl	Dtsch Arztebl Int 108(31-32):525-31 (2011)
245	2010	Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.	+	-	nl	Health Technol Assess 14(Suppl. 2):33-9 (2010)
246	2010	Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.	+	-	nl	Health Technol Assess 14(Suppl. 2):71-9 (2010)
247	2010	Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.	+	-	nl	Health Technol Assess 14 Suppl 1(-):47-53 (2010)
248	2010	Recent development of molecular-targeted drugs in lung cancer.	+	-	nl	Intern Med 49(18):1923-34 (2010)
249	2008	Clinical relevance of sputum cytology and chest X-ray in patients with suspected lung tumors.	+	-	nl	Intern Med 47(13):1199-205 (2008)
250	2011	Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer: a systematic review.	+	-	nl	Chin Med J (Engl) 124(10):1563-8 (2011)
251	2004	Central nervous system metastases of a pulmonary epitheloid haemangioendothelioma.	+	-	nl	Eur Respir J 23(3):483-6 (2004)
252	2009	Differential diagnosis and management of focal ground-glass opacities.	+	-	nl	Eur Respir J 33(4):821-7 (2009)
253	2009	First- and second-line therapy for advanced nonsmall cell lung cancer.	+	-	nl	Eur Respir J 33(4):915-30 (2009)
254	2005	Reconstruction of chest wall defects after resection of large neoplasms: ten-year experience.	+	-	nl	Interact Cardiovasc Thorac Surg 4(3):250-5 (2005)
255	2010	Occupational lung cancer.	+	-	nl	J Bras Pneumol 36(6):784-94 (2010)
256	2009	Role of immunohistochemistry in the diagnosis of lung cancer.	+	-	nl	J Bras Pneumol 35(4):375-82 (2009)
257	2008	Histological diagnosis of lung cancer micrometastases.	+	-	nl	J Bras Pneumol 34(3):127-8 (2008)
258	2007	Staging non-small cell lung cancer.	+	-	nl	Cancer Imaging 7(-):148-59 (2007)
259	2008	Radiofrequency ablation of pulmonary tumours: current status.	+	-	nl	Cancer Imaging 8(-):27-35 (2008)
260	2008	Lung tumour ablation - where are we now?	+	-	nl	Cancer Imaging 8(-):116-7 (2008)
261	2006	Unusual lung tumours: an illustrated review of CT features suggestive of this diagnosis.	+	-	nl	Cancer Imaging 6(-):72-82 (2006)
262	2003	Image-guided conformal radiation therapy planning and delivery for non-small-cell lung cancer.	+	-	nl	Cancer Control 10(4):277-88 (2003)
263	2003	New approaches for small-cell lung cancer: local treatments.	+	-	nl	Cancer Control 10(4):289-96 (2003)
264	2003	Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer.	+	-	nl	Cancer Control 10(4):297-305 (2003)
265	2003	A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest.	+	-	nl	Cancer Control 10(4):306-14 (2003)
266	2008	Functional lung imaging in thoracic cancer radiotherapy.	+	-	nl	Cancer Control 15(2):112-9 (2008)
267	2004	Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer.	+	-	nl	Q J Nucl Med Mol Imaging 48(2):119-42 (2004)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.